Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
breast cancer
Positive results of cancer treatment to be presented at Boston conference
Results of a cancer treatment in the treatment of gynecologic and breast cancer are to…
November 3, 2022 - 2 minutes
Positive results from study of drug to treat patients with breast cancer published
Results from a phase 1b study of a drug to treat patients with androgen receptor…
September 29, 2022 - 3 minutes
Ghana first to benefit from Roche partnership with Jhpiego to improve cervical and breast cancer outcomes for women
Roche has signed a memorandum of understanding (MoU) with the Johns Hopkins Program for International…
September 16, 2022 - 3 minutes
Reveal Genomics reveals more HER2DX breast cancer validation data
Reveal Genomics, S.L. says it has received more validation of HER2DX, the world's first specialized…
September 12, 2022 - 3 minutes
Lutris Pharma radiation trial brings positive results for breast cancer patients
Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD)…
September 8, 2022 - 4 minutes
Ibex reports positive outcomes for AI-supported diagnosis of breast cancer
Ibex Medical Analytics have just announced positive outcomes for its Galen Breast solution in diagnosing…
September 2, 2022 - 4 minutes
Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy
All of Everest Medicine's development and commercialization rights for a breast cancer drug called Trodelvy…
August 19, 2022 - 3 minutes
Sanofi drops amcenestrant clinical development program
Sanofi says it is discontinuing the global clinical development program of amcenestrant, an investigational oral…
August 17, 2022 - 2 minutes
Companies unite to bolster diagnostics for cancer and liver disease
Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease…
June 28, 2022 - 2 minutes
Breast cancer drug recommended for approval
A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of…
June 28, 2022 - 3 minutes
New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer
Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an…
June 21, 2022 - 3 minutes
